Instem at ICT 2022
Helping our clients bring their life enhancing products to market faster
Please stop by one of our booths to learn more about Instem’s powerful software solutions & services
Preclinical Solutions - Booth #18
Learn how Instem’s preclinical solutions keep our clients focused on their science, not their software.
- Provantis® is the #1 online solution for managing preclinical studies.
- Learn about submit™, the most widely adopted modular software suite for creating, reviewing and managing SEND data or ask our SEND experts about our new SEND Advantage services.
- Our Genetic Tox Solutions are in a class of their own, featuring Comet Assay IV and Cyto Study Manager.
In Silico Solutions - Booth #19
Learn how our software and outsourced services enable researchers to generate new scientific insights through the identification, extraction and analysis of data to create actionable information.
- KnowledgeScan™ Target Safety Assessment (TSA) Service: Delivering comprehensive TSAs for clients around the world, enabling them to make faster, better-informed decisions on their drug targets.
- Leadscope Model Applier: Easy-to-use software to apply prediction models, perform an expert review, and create reports.
- Genetic Toxicity (Q)SARs: Complete solutions for the computational assessment of genetic toxicity, including statistical-based and expert rule-based models.
- Predict™: A leading edge, technology-enabled service that delivers a combination of powerful computation models with expert scientific review, to help clients predict chemical safety more quickly, efficiently, and comprehensively.
Poster Presentations:
P21-01 – Poster Viewing II (PV02), Tuesday 20 September
Challenges and Practical Examples in Creation of SEND Data for Developmental and Reproductive Toxicity Studies
Co-authored: Showa University School of Medicine, G-SEND (Global SEND Alliance), Ina Research Inc., Instem
Poster Viewing 1, Monday, September 19th, 2022, 1.00pm-2.00pm / e-poster number is LP-119
EMA-Mutamind: Which properties determine the mutagenicity of API- derived nitrosamines?
Presenter: Kevin Cross, VP Product Development, Instem Co-authored by; A. Bassan, I. Brandsma, S. Chang, M. Christmann, M.A. Djuari, U. Deppenmeier, L. Elenschneider, J. Fahrer, R. Frötschl, G. Johnson, B. Haas, T. Hansen, A. Londenberg, T. Osterlund, M. Schulz, M. Vogel, C. Ziemann and S.E. Escher